ID: ALA404135

Max Phase: Preclinical

Molecular Formula: C17H23N3O7

Molecular Weight: 381.39

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)C(=O)N[C@H]1/C(=N/OC(=O)Nc2ccccc2)O[C@H](CO)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C17H23N3O7/c1-9(2)15(24)19-12-14(23)13(22)11(8-21)26-16(12)20-27-17(25)18-10-6-4-3-5-7-10/h3-7,9,11-14,21-23H,8H2,1-2H3,(H,18,25)(H,19,24)/b20-16-/t11-,12-,13-,14-/m1/s1

Standard InChI Key:  QIDNPKQVOUOABR-SLFIBHSGSA-N

Associated Targets(Human)

N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 10 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Beta-hexosaminidase 11 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 381.39Molecular Weight (Monoisotopic): 381.1536AlogP: -0.20#Rotatable Bonds: 5
Polar Surface Area: 149.71Molecular Species: NEUTRALHBA: 8HBD: 5
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.76CX Basic pKa: CX LogP: 0.24CX LogD: 0.24
Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.35Np Likeness Score: 0.11

References

1. Stubbs KA, Balcewich M, Mark BL, Vocadlo DJ..  (2007)  Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated beta-lactam resistance.,  282  (29): [PMID:17439950] [10.1074/jbc.m700084200]

Source